The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Under the Radar

Under the Radar

November 1, 2013 • By Sarah Schafer, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • Speak Out Rheum: Under the Radar
  • Why Antiphospholipid Antibody Syndrome Should Be On Your Radar
  • Put Hughes Syndrome on Your Radar
Explore This Issue
November 2013
Also By This Author
  • Speak Out Rheum: Under the Radar
The Future Is Bright
Fatigue can be one of the most burdensome symptoms for patients with Sjögren’s syndrome.


As a medical student, I was not prone to diagnosing myself with the “disease du jour.” A distance swimmer and triathlete, I imagined myself to be one of the least likely people to develop a chronic disease in the prime of my life. But it happened.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In retrospect, there were warning signs. My eyes had been dry and irritated since adolescence. An unusual fatigue had been building for years. At age 44, following a minor surgical procedure on an injured disc, my health disintegrated suddenly and rapidly. I developed overwhelming fatigue, constant migraines, abdominal pain, nausea, and diarrhea. It felt as though every cell in my body was soaking in a toxic marinade. At first, this seemed to be caused by a medication reaction. Yet the puzzling array of symptoms worsened as the months went by.

None of my doctors suspected Sjögren’s syndrome, despite a suggestive history, including punctual cautery for severe dry eyes, chronic sinusitis, muscle pain, and stubborn tendonitis affecting multiple joints. After an unremarkable gastrointestinal workup, I was told that I probably had a severe form of irritable bowel syndrome. It was obvious to me that something much more serious was going on and it was not just affecting my gut.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

One year into this ordeal, I had done enough research to suspect Sjögren’s as the probable culprit. Despite testing negative for Sjögren’s antibodies, I insisted on a rheumatology referral and a minor salivary gland biopsy. The biopsy was abnormal, yet it was discounted because of a low focus score. Despite an unclear diagnosis, I started prednisone. In just a matter of days, my gastrointestinal symptoms remarkably improved. So much for irritable bowel!

I have had the good fortune to work with an excellent rheumatologist who was willing to treat me in those early years as “probable Sjögren’s,” based on the clinical picture. Seven years into the illness, a second salivary gland biopsy confirmed my diagnosis.

The Problem with Diagnosis

Most people in my situation would have been told that they did not have Sjögren’s. I know women with similar stories who were told their symptoms were due to stress or menopause (90% of patients with Sjögren’s are women). Because depression, thyroid disease, celiac, and fibromyalgia are common comorbidities in patients with Sjögren’s, they can distract providers from looking for an underlying cause that connects the scattered symptoms.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 | Single Page

Filed Under: Profiles Tagged With: Diagnosis, physician, Sjögren's syndrome, symptomsIssue: November 2013

You Might Also Like:
  • Speak Out Rheum: Under the Radar
  • Why Antiphospholipid Antibody Syndrome Should Be On Your Radar
  • Put Hughes Syndrome on Your Radar
  • Sjögren’s Syndrome Moves into the Spotlight

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)